David G. Hunter is president of the American Association for Pediatric Ophthalmology and Strabismus, a professor of ophthalmology at Harvard Medical School and co-founder of the medical device company Rebion.
I remember the day I first put on eyeglasses at age 8. Stepping out of the optical shop, I saw individual leaves on trees and blades of grass with shock and wonder — details that had been invisible blurs just moments before because I had developed myopia. That is, I had become nearsighted.
The post This drug treats myopia. I’m sick of telling patients they can’t have it. appeared first on Washington Post.
